Additional Information NDA 206488 Exondys 51 (eteplirsen) Approval

The documents linked on this page have been redacted for certain information that is exempt from disclosure under the Freedom of Information Act, 5 U.S.C. sec. 552. This includes, for example, trade secret information, confidential commercial information, predecisional/deliberative-process information, and personal privacy information. The full text of any published materials within this document collection, including newspaper and journal articles, will not be posted to this website because such material is copyright protected.

Date created: July 31, 2017, updated November 24, 2017

Back to Top    Drugs@FDA

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English